Eximo Medical Ltd.
https://www.eximomedical.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Eximo Medical Ltd.
Scrip Asks…What Does 2024 Hold For Biopharma? Part 6: Therapeutic Area Advances
More than 100 biopharma executives and experts told Scrip their predictions for therapeutic area advances in the coming year. The recent commercial success of GLP-1s in diabetes and obesity and their potential in further disease areas fuelled excitement around the metabolic space. Expectations were also positive in neurology following the launch of Leqembi for Alzheimer’s disease in 2023, while the multiple opportunities to improve cancer treatment kept oncology top of the pile overall.
Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances
Neuroscience and oncology fuel high hopes for therapeutic R&D progress among 90-plus surveyed biopharma industry leaders.
Accelmed Launches New $100M Venture Medtech Fund
Israeli healthtech fund Accelmed is raising $100m for its fourth fund focused on medical device and digital health companies.
Mendor Ltd.
Mendor Ltd. says it’s unique in the diabetes space because it has integrated its diagnostic blood glucose meter Discreet with a software application for tailoring patient pharmaceutical treatment. Using the device, which contains a built-in lancing pen and cartridge within a cell-phone-sized plastic cover, diabetics can take their glucose readings in less than 20 seconds, even on the run.
Company Information
- Industry
-
Medical Devices
- Laser
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Other Names / Subsidiaries
-
- Eximo Hybrid Medical Technologies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice